Clinical features, laboratory and operative findings were reviewed in 10 cases of Ebstein's anomaly admitted to Dong San Hospital, Keimyung University during a 7(1/2)-year period from January 1982 to June 1989. The following results obtained : 1) Exertional dyspnea(90%) and palpitation(30%) were the predominant symptoms, and cyanosis was documented in 2 cases among 10 patients. 2) Chest X-ray showed cardiomegaly in all cases, but cardio-thoracic ratio was above 0.6 in 4 cases. 3) Electrocardiograms showed RBBB in 4 cases, RVH in 2 cases, 1st degree AV block in 4 cases. 4) Echocardiograms and angiograms showed displacement of tricuspid valve in all cases. 5) Interatrial communication via atrial septal defect (5) and patent foramen ovale (5) was present in 10 cases(100%). 6) Operative findings of 5 cases showed abnormalities of septal leaflet in 5(100%), posterior leaflet in 5(100%), and anterior leaflet in 1 case (20%).
Atrioventricular Block ; Cardiomegaly ; Cyanosis ; Ebstein Anomaly* ; Electrocardiography ; Foramen Ovale, Patent ; Heart Septal Defects, Atrial ; Humans ; Thorax ; Tricuspid Valve

Isolated right ventricular hypoplasia, unassociated with severe pulmonary or tricuspid valvar malformations, is a rare primary congenital cardiac anomaly in which of the trabecular portion of right ventricle fails to develop. An atrial septal defect or a patent foramen ovale serves as an escape valve. We observed a 2-day-old neonate with this disorder who suffered from cyanosis. The diagnosis was made by Doppler-echocardiography which revealed marked reduction in right ventricular size and right-to-left shunt through the atrial septal defect. There was no other cardiac malformation such as pulmonary atresia or tricuspid atresia.
Cyanosis ; Diagnosis ; Foramen Ovale, Patent ; Heart Defects, Congenital ; Heart Septal Defects, Atrial ; Heart Ventricles ; Humans ; Infant, Newborn ; Pulmonary Atresia* ; Tricuspid Atresia* ; United Nations

PURPOSE: Transcatheter closure of patent foramen ovale (PFO), atrial septal defect (ASD) and patent ductus arteriosus (PDA) is a new and less traumatic technique than open heart surgery. One of the more popular occluding devices is the Amplatzer(R) septal occluder which is made of nitinol. The present study was undertaken to evaluate the safety and release of nickel after implantation of Amplatzer(R) occluder in patients with PFO, ASD and PDA. METHODS: Random blood samples were obtained from 25 patients with Amplatzer(R) PFO, ASD, PDA occluder during 4-year and 7-month post closure period. The nickel content in the specimens was determined using atomic absorption spectrometer. RESULTS: All patients showed satisfactory clinical improvements and there was no echocardiographic evidence of complications. During the post closure, concentrations of nickel in serum were within normal range with values 0.2 ug/dL. CONCLUSION: Nickel seems to be released from Amplatzer(R) occluder. The dissolusion of nickel from Amplatzer(R) occluder is minimal and systemic rise in serum levels of nickel are within normal range. However, further studies are needed to evaluate biological effects in patients with nickel hypersensitivity.
Absorption ; Ductus Arteriosus, Patent ; Echocardiography ; Foramen Ovale, Patent ; Heart Septal Defects, Atrial ; Humans ; Hypersensitivity ; Nickel* ; Reference Values ; Septal Occluder Device ; Thoracic Surgery

PURPOSE: Transcatheter closure of atrial septal defects (ASD) is currently established therapy as an alternative to surgery. But rarely, complications are reported in some studies. We report early and intermediate term complications associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder (ASO). METHODS: From June 2003 to May 2006, 64 patients underwent transcatheter closure of secundum ASD or patent foramen ovale using the ASO. The ratio of male to female was 1:2.4, the median age was 17 years (range: 2.6-64 years) and their median weight was 47.5 kg (range: 2.6-64 kg). RESULTS: The median diameter of ASD measured with transthoracic or transesophageal echocardiography was 15 mm (range: 6-28 mm), the median balloon stretched diameter was 18 mm (range: 6.5-34 mm), and the median size of device was 19.5 mm (range: 6-36 mm), was little difference with balloon stretched diameter. There were 10 cases of complications: arrhythmia (2), device malformation (2), aorta to right atrial fistula (1), hemolytic anemia (1), mitral valve encroachment (1), malposition (1), residual shunt (1), and inferior vena cava perforation (1). CONCLUSION: Transcatheter closure of ASD using ASO is effective and safe therapy. However, significant complications such as aorta to atrial fistula, atrial erosion, or device embolization can happen, so an appropriate selection of patient and device in relevance to size and anatomy of ASD is important for successful closure.
Anemia, Hemolytic ; Aorta ; Arrhythmias, Cardiac ; Echocardiography, Transesophageal ; Female ; Fistula ; Foramen Ovale, Patent ; Heart Septal Defects, Atrial ; Humans ; Male ; Mitral Valve ; Septal Occluder Device ; Vena Cava, Inferior

Infrequently, patent foramen ovale or atrial septal defect act as a passage for the venous thrombi to reach the arterial circulation. These arterial thrombi can evoke tragic paradoxical embolisms. We report a case of impending paradoxical embolism due to a huge thrombus trapped through a patent foramen ovale in a 66-year-old man who presented with sudden dyspnea and chest discomfort in ten days after colon cancer surgery. The transthoracic echocardiogram demonstrated signs of acute right ventricular pressure overload and a huge linear mass wedged in a patent foramen ovale. On the intraoperative transesophageal echocardiography, the huge linear mass was freely floating in both right and left cardiac chambers passing through atrial septum. To prevent paradoxical embolism from this thrombus, he underwent emergent embolectomy and about 25 cm sized linear thrombus entrapped PFO was successfully removed.
Aged ; Atrial Septum ; Colonic Neoplasms ; Dyspnea ; Echocardiography, Transesophageal ; Embolectomy ; Embolism, Paradoxical* ; Foramen Ovale, Patent* ; Heart Septal Defects, Atrial ; Humans ; Pulmonary Embolism ; Thorax ; Thrombosis ; Ventricular Pressure

Heart Septal Defects, Atrial*

The percutaneous transcatheter closure of secundum atrial septal defect has recently become an increasingly widespread alternative to surgical closure in many centers. Although immediate, short, and intermediate term results of percutaneous transcatheter septal closure are promising, the procedure is not free from inherent complications that could be lethal. We report a case of device embolization necessitating emergent surgical retrieval.
Heart Septal Defects, Atrial

No abstract available.
Heart Septal Defects, Atrial*

No abstract available.
Heart Septal Defects, Atrial*

No abstract available.
Heart Septal Defects, Atrial